Leggett & Platt Q2 Sales Top Estimates, but Negative Operating Cash Flow and Merger Costs Cloud the Picture
LEG sits 17% above its 52-week low of $8.32 on light trading volume (0.2× avg).
Summary
Leggett & Platt's Q2 sales of $1.0 billion beat estimates, but operating cash flow turned negative and merger/restructuring costs weighed on earnings. Goodwill impairment risk and Chinese tax disputes add uncertainty as the Somnigroup acquisition vote approaches.
Key Events · Earnings and Guidance · LEG
-
Q2 Sales Beat, But Cash Flow Deteriorates
Net trade sales of $999.7M beat the $982.86M consensus, but operating cash flow swung to a $(10)M outflow in H1 2026, down $101M YoY, driven by a $103M increase in receivables.
-
Merger and Restructuring Costs Weigh on Earnings
Somnigroup merger costs of $13.6M and restructuring charges of $15.2M reduced EBIT. The 2026 Restructuring Plan was expanded, with total expected costs now $25M.
-
Goodwill Impairment Risk Emerges
Home Furniture reporting unit's fair value exceeds carrying value by less than 5%; a 1% increase in the discount rate would trigger impairment. Bedding and Work Furniture units have only a 10% cushion.
-
Chinese Tax Assessments Total $24.5M
Three Chinese subsidiaries received formal tax assessments alleging failure to satisfy beneficial owner requirements. Payments were made as guarantor to preserve appeal rights; no expense recorded.
Analysis · LEG · Manufacturing
While Leggett & Platt's Q2 sales of $1.0 billion exceeded consensus, the more pressing concern is the sharp erosion in cash generation—operating cash flow swung to a $10 million outflow in the first half, driven by a $101 million working capital drag. Earnings were further pressured by $14 million in Somnigroup merger costs and $15 million in restructuring charges. Adding to the uncertainty, the company disclosed that its Home Furniture reporting unit's fair value exceeds carrying value by less than 5%, putting $68.5 million of goodwill at risk if conditions worsen. Three Chinese tax assessments totaling $24.5 million introduce regulatory risk, though no expense has been recorded. Against the backdrop of the pending Somnigroup acquisition, these results highlight operational strain and balance sheet pressures that shareholders should monitor ahead of the August 20 merger vote.
At the time of this filing, LEG was trading at $9.76 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $8.32 to $13.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.